Showing results (201-210 of 299) with videos related to
Sort By:
Pageof 30
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
5-Fluorouracil, folinic acid, etoposide and cisplatin chemotherapy for locally advanced or metastatic carcinoma of the oesophagusM Stahl, H Wilke, H J Meyer, et al.Cancer|October 1, 1993
Cardiotoxicity of 5-fluorouracil in combination with folinic acid in patients with gastrointestinal cancerC Schöber, E Papageorgiou, A Harstrick, et al.Journal of Cancer Research and Clinical Oncology|January 1, 1991
Cisplatin/etoposide/ifosfamide stepwise dose escalation with concomitant granulocyte/macrophage-colony-stimulating factor for patients with far-advanced testicular carcinomaA Harstrick, H J Schmoll, C Bokemeyer, et al.Cancer Research|February 24, 2001
D-24851, a novel synthetic microtubule inhibitor, exerts curative antitumoral activity in vivo, shows efficacy toward multidrug-resistant tumor cells, and lacks neurotoxicityG Bacher, B Nickel, P Emig, et al.Klinische Wochenschrift|August 15, 1980
[Sequential combination chemotherapy with vinblastine/bleomycin and adriamycin/cis-dichlorodiammineplatinum (II) in non-seminomatous testicular cancer. I. Results of a prospective randomized phase III-study with 71 patients with disseminated disease (stage IV) (author's transl)]M E Scheulen, M Higi, R B Schilcher, et al.Leukemia Research|February 1, 1996
Analysis of the novel cyclin-dependent kinase 4 and 6 inhibitor gene p18 in lymphoma and leukemia cell linesR Siebert, C P Willers, A Fosså, et al.Human Reproduction (Oxford, England)|November 20, 2004
DNA sequence variations of the entire anti-Mullerian hormone (AMH) gene promoter and AMH protein expression in patients with the Mayer-Rokitanski-Kuster-Hauser syndromeP Oppelt, P L Strissel, A Kellermann, et al.Cancer Chemotherapy and Pharmacology|June 15, 2000
Investigation of bioavailability and pharmacokinetics of treosulfan capsules in patients with relapsed ovarian cancerR A Hilger, G Jacek, C Oberhoff, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 1, 1990
High dose epirubicin in refractory or relapsed non-seminomatous testicular cancer: a phase II studyA Harstrick, H J Schmoll, H Wilke, et al.Seminars in Oncology|December 1, 1994
The role of granulocyte-macrophage colony-stimulating factor in the treatment of germ cell tumors. German Testicular Cancer Study GroupC Bokemeyer, A Harstrick, U Rüther, et al.Pageof 30